Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C164 - Clinical EMG 1: Nerve Conduction Studies and Needle EMG: Patterns in Neuromuscular Disorders

Wednesday 04/17/24
01:00 PM - 03:00 PM MDT Add To Calendar
Colorado Convention Center | Four Seasons 2/3
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Kelly G. Gwathmey, MD
Neuromuscular and Clinical Neurophysiology (EMG)
Participants should understand the basic concepts underlying nerve conduction studies including pitfalls and technical factors appreciate common nerve conduction patterns in neuromuscular disorders; apply needle EMG for the diagnosis of neuromuscular disorders. This program complements Clinical EMG 2: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography, but covers independent topics.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM MDT Introduction Introduction
Kelly G. Gwathmey, MD
01:05 PM - 01:35 PM MDT Speaker Approach to Nerve Conduction Studies
Kelly G. Gwathmey, MD
01:35 PM - 02:10 PM MDT Speaker Nerve Conduction Studies: Clinical Patterns in Neuromuscular Disorders
Ruple S. Laughlin, MD, FAAN
02:10 PM - 02:45 PM MDT Speaker Needle EMG: Clinical Patterns in Neuromuscular Disorders
Aaron E. Izenberg, MD
02:45 PM - 03:00 PM MDT Q&A Questions & Answers
Kelly G. Gwathmey, MD, Ruple S. Laughlin, MD, FAAN, Aaron E. Izenberg, MD
Faculty Disclosures
Kelly G. Gwathmey, MD Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Ruple S. Laughlin, MD, FAAN Dr. Laughlin has nothing to disclose.
Aaron E. Izenberg, MD Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexxion. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alnylam.